BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12038703)

  • 1. Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women.
    Fabjani G; Tong D; Czerwenka K; Schuster E; Speiser P; Leodolter S; Zeillinger R
    Breast Cancer Res Treat; 2002 Mar; 72(2):131-7. PubMed ID: 12038703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients.
    Tong D; Fabjani G; Heinze G; Obermair A; Leodolter S; Zeillinger R
    Int J Cancer; 2001 Nov; 95(6):394-7. PubMed ID: 11668524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia.
    Albalawi IA; Mir R; Abu-Duhier FM
    Endocr Metab Immune Disord Drug Targets; 2020; 20(5):760-770. PubMed ID: 31763970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.
    Tokunaga E; Okada S; Yamashita N; Akiyoshi S; Kitao H; Morita M; Kakeji Y; Maehara Y
    Breast Cancer; 2012 Apr; 19(2):161-9. PubMed ID: 21063923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
    Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
    Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity in tumor tissue in hormonal receptor genes is associated with poor prognostic criteria in breast cancer.
    Iobagiu C; Lambert C; Raica M; Lima S; Khaddage A; Peoc'h M; Genin C
    Cancer Genet; 2015 Apr; 208(4):135-42. PubMed ID: 25979597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
    Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
    Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.
    Romano A; Lindsey PJ; Fischer DC; Delvoux B; Paulussen AD; Janssen RG; Kieback DG
    Gynecol Oncol; 2006 May; 101(2):287-95. PubMed ID: 16360811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?
    Lattuada D; Somigliana E; Viganò P; Candiani M; Pardi G; Di Blasio AM
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):190-4. PubMed ID: 15272913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer.
    Tokunaga E; Yamashita N; Kitao H; Tanaka K; Taketani K; Inoue Y; Saeki H; Oki E; Oda Y; Maehara Y
    Breast; 2016 Feb; 25():62-8. PubMed ID: 26577950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma.
    Pijnenborg JM; Romano A; Dam-de Veen GC; Dunselman GA; Fischer DC; Groothuis PG; Kieback DG
    J Pathol; 2005 Apr; 205(5):597-605. PubMed ID: 15726651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone.
    Romano A; Delvoux B; Fischer DC; Groothuis P
    J Mol Endocrinol; 2007 Feb; 38(1-2):331-50. PubMed ID: 17293450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
    Tas F
    Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
    Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
    J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis.
    van Kaam KJ; Romano A; Schouten JP; Dunselman GA; Groothuis PG
    Hum Reprod; 2007 Jan; 22(1):129-35. PubMed ID: 16920727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas.
    de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ
    Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.
    Leite DB; Junqueira MG; de Carvalho CV; Massad-Costa AM; Gonçalves WJ; Nicolau SM; Lopes LA; Baracat EC; da Silva ID
    Steroids; 2008 Jul; 73(6):676-80. PubMed ID: 18384825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.